FI118295B - Intranasaalinen migreeninvastainen koostumus - Google Patents

Intranasaalinen migreeninvastainen koostumus Download PDF

Info

Publication number
FI118295B
FI118295B FI964095A FI964095A FI118295B FI 118295 B FI118295 B FI 118295B FI 964095 A FI964095 A FI 964095A FI 964095 A FI964095 A FI 964095A FI 118295 B FI118295 B FI 118295B
Authority
FI
Finland
Prior art keywords
hyvin
composition
chitosan
pharmaceutically acceptable
acid
Prior art date
Application number
FI964095A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI964095A0 (fi
FI964095A (fi
Inventor
Marc Karel Jozef Francois
Lisbeth Illum
Roger Carolus August Embrechts
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI964095A0 publication Critical patent/FI964095A0/fi
Publication of FI964095A publication Critical patent/FI964095A/fi
Application granted granted Critical
Publication of FI118295B publication Critical patent/FI118295B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI964095A 1994-04-13 1996-10-11 Intranasaalinen migreeninvastainen koostumus FI118295B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP94200998 1994-04-13
EP94200998 1994-04-13
EP9501302 1995-04-10
PCT/EP1995/001302 WO1995028158A1 (en) 1994-04-13 1995-04-10 Intranasal antimigraine composition

Publications (3)

Publication Number Publication Date
FI964095A0 FI964095A0 (fi) 1996-10-11
FI964095A FI964095A (fi) 1996-10-11
FI118295B true FI118295B (fi) 2007-09-28

Family

ID=8216793

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964095A FI118295B (fi) 1994-04-13 1996-10-11 Intranasaalinen migreeninvastainen koostumus

Country Status (23)

Country Link
EP (1) EP0755253B1 (xx)
JP (1) JP2921988B2 (xx)
KR (1) KR100219952B1 (xx)
CN (1) CN1146151A (xx)
AT (1) ATE194915T1 (xx)
AU (1) AU684360B2 (xx)
BG (1) BG62197B1 (xx)
BR (1) BR9507369A (xx)
CA (1) CA2184822C (xx)
CZ (1) CZ286610B6 (xx)
DE (1) DE69518149T2 (xx)
FI (1) FI118295B (xx)
HR (1) HRP950149A2 (xx)
HU (1) HU219495B (xx)
IL (1) IL113341A (xx)
NO (1) NO310276B1 (xx)
NZ (1) NZ284454A (xx)
PL (1) PL179761B1 (xx)
RO (1) RO115414B1 (xx)
SI (1) SI9500121A (xx)
SK (1) SK129896A3 (xx)
WO (1) WO1995028158A1 (xx)
ZA (1) ZA953038B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970032844A (ko) * 1995-12-29 1997-07-22 김준웅 지속성 경비투여제제
UA72189C2 (uk) * 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
GB2378383A (en) * 2001-06-06 2003-02-12 Gursharan Moonga Nasal delivery of pharmaceutical compositions in powder form
GB0328186D0 (en) * 2003-12-05 2004-01-07 West Pharm Serv Drug Res Ltd Intranasal compositions
US7968122B2 (en) 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
GB8904370D0 (en) * 1989-02-25 1989-04-12 Cosmas Damian Ltd Liquid delivery compositions
SI9300097B (en) * 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
JPH0656675A (ja) * 1992-08-07 1994-03-01 Nippon Soda Co Ltd 家畜の乳房炎予防剤

Also Published As

Publication number Publication date
PL179761B1 (pl) 2000-10-31
CZ286610B6 (cs) 2000-05-17
SI9500121A (en) 1995-10-31
CA2184822C (en) 2000-12-19
NO310276B1 (no) 2001-06-18
WO1995028158A1 (en) 1995-10-26
HU219495B (hu) 2001-04-28
FI964095A0 (fi) 1996-10-11
NZ284454A (en) 1997-12-19
BG100889A (en) 1997-07-31
HUT75939A (en) 1997-05-28
IL113341A0 (en) 1995-07-31
IL113341A (en) 2000-08-31
ATE194915T1 (de) 2000-08-15
PL316756A1 (en) 1997-02-03
JPH09505606A (ja) 1997-06-03
JP2921988B2 (ja) 1999-07-19
BG62197B1 (bg) 1999-05-31
AU2305495A (en) 1995-11-10
KR100219952B1 (ko) 1999-09-01
HU9602806D0 (en) 1996-11-28
AU684360B2 (en) 1997-12-11
EP0755253A1 (en) 1997-01-29
HRP950149A2 (en) 1997-06-30
CN1146151A (zh) 1997-03-26
SK129896A3 (en) 1997-05-07
CA2184822A1 (en) 1995-10-26
RO115414B1 (ro) 2000-02-28
ZA953038B (en) 1996-10-14
BR9507369A (pt) 1997-09-23
DE69518149T2 (de) 2001-03-22
NO964333L (no) 1996-10-11
EP0755253B1 (en) 2000-07-26
FI964095A (fi) 1996-10-11
NO964333D0 (no) 1996-10-11
CZ292096A3 (en) 1997-02-12
DE69518149D1 (de) 2000-08-31

Similar Documents

Publication Publication Date Title
RU1837869C (ru) Способ получени дисперсии полипептидов дл интраназольного применени
US5897858A (en) Nasal spray compositions exhibiting increased retention in the nasal cavity
JP4430067B2 (ja) ロチゴチンの鼻腔内用処方
JP3350061B2 (ja) エレトリプタンヘミスルフェートおよびカフェインを含有する医薬組成物
Loftsson et al. Topically effective ocular hypotensive acetazolamide and ethoxyzolamide formulations in rabbits
CN1126535C (zh) 鼻内给药的水悬浮液
CH684192A5 (fr) Médicaments renfermant un sel de 3-(2-(diméthylamino)éthyl)-N-méthyl-1H-indole-5-méthanesulfonamide.
NZ531792A (en) Compositions for treatment of common cold
US20040166067A1 (en) Pharmaceutical compositions
JP2002356424A (ja) １，２，３，９−テトラヒドロ−９−メチル−３−［（２−メチル−１ｈ−イミダゾール−１−イル）メチル］−４ｈ−カーバゾール−４−オンを有效成分とする鼻腔噴霧用組成物
FI118295B (fi) Intranasaalinen migreeninvastainen koostumus
JP2003512329A (ja) シクレソニド含有粘膜投与用医薬組成物
US6054462A (en) Intranasal antimigraine compositions
WO2001035926A2 (en) An improved pharmaceutical composition for treating male erectile dysfunction
KR20100029829A (ko) 텔비부딘을 함유하는 경구 제약 용액제
FR2680106A1 (fr) Procede de realisation de formes pharmaceutiques stables d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues.
JPH01160916A (ja) ドーパミン経鼻投与製剤
KR101170548B1 (ko) 치환된 이미다졸 유도체를 함유하는 개선된 제형
WO2007107835A2 (en) Stable liquid formulations of antiepileptic agents
EP0323762B1 (fr) Nouvelles compositions anti-tussives et leur procédé d'obtention
JPH0157089B2 (xx)

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 118295

Country of ref document: FI

MA Patent expired